Nirsevimab
Nirsevimab (MEDI8897) is a recombinant monoclonal antibody against human respiratory syncytial virus (RSV) . Nirsevimab has neutralizing activity against RSV A and RSV B viruses, with IC50 values of 5.42 ng/mL and 9.71 ng/mL, respectively. Nirsevimab can be used for research on respiratory infections[1][2].
Product Specifications
CAS Number
[1989556-22-0]
Product Name Alternative
MEDI8897
UNSPSC
12352203
Target
RSV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/nirsevimab.html
Purity
98.00
Solubility
10 mM in DMSO
Smiles
[Nirsevimab]
Molecular Weight
(146.31 kDa)
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99756/Nirsevimab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99756/Nirsevimab-SDS-MedChemExpress.pdf
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Human adenovirus 5/HAdV-5 L3/CP-H/Protein II Protein, N-His
Recombinant Human adenovirus 5/HAdV-5 L3/CP-H/Protein II Protein, N-His
Recombinant Human adenovirus 5/HAdV-5 L3/CP-H/Protein II Protein, N-His
